| #153 |
Eric C. Rosen |
Qualcomm |
1 |
| #153 |
Sarah Hume Buta |
C/Hca |
1 |
| #153 |
Evgeniy Leyvi |
Koniniklijke Philips N.V. |
1 |
| #153 |
Nikita Chugunov |
Schlumberger Technology |
1 |
| #153 |
Desai Chen |
Inkbit |
1 |
| #153 |
Turusan Kolcuoglu |
— |
1 |
| #153 |
Charles P. Lin |
The General Hospital |
1 |
| #153 |
Shekhar Bangalore Sastry |
Simplisafe |
1 |
| #153 |
Alexander J. Kieft |
Openexchange |
1 |
| #153 |
Suraj Deepak Bramhavar |
MIT |
1 |
| #153 |
Yakov E. Kutsovsky |
Cabot |
1 |
| #153 |
Patrick Eaton |
Emc |
1 |
| #153 |
Gerald J. O'Neill |
Hampshire Chemical |
1 |
| #153 |
Jorden Kass |
Enanta Pharmaceuticals |
1 |
| #153 |
Adam Rodriguez |
Google |
1 |
| #153 |
Jamie Gordon Nichol |
American Messaging Services |
1 |
| #153 |
Michelle Mader |
Pfizer |
1 |
| #153 |
Edward J. Miracco |
Modernatx |
1 |
| #153 |
Stephen Shenefield |
Boston Acoustics |
1 |
| #153 |
Julian Levell |
Novartis Ag |
1 |
| #153 |
Anders M. Naar |
The General Hospital |
1 |
| #153 |
Nazila Salamat-Miller |
Shire Human Genetic Therapies |
1 |
| #153 |
Shrinivas Pundlik |
Schepens Eye Research Institute |
1 |
| #153 |
Mark Strohmeier |
Vertex Pharmaceuticals Incorporated |
1 |
| #153 |
Mildred Dresselhaus |
MIT |
1 |
| #153 |
Franck Léon Pérot |
Dassault Systemes Simulia |
1 |
| #153 |
Maia Stapleton Mukherjee |
Xyleco |
1 |
| #153 |
Johnson Qu |
Paramount Pictures |
1 |
| #153 |
Ping Yin |
Bioaxone Biosciences |
1 |
| #153 |
Arthur Reis |
Brandeis University |
1 |
| #153 |
Sachin Maniar |
Sanofi |
1 |
| #153 |
Richin Jain |
Here Global B.V. |
1 |
| #153 |
Vitaly Mayatskikh |
Emc Ip Holding Company |
1 |
| #153 |
Nils Homer |
Thermo Fisher |
1 |
| #153 |
Darwin Keith-Lucas |
Smith & Nephew |
1 |
| #153 |
Dan John Lauber |
E Ink Holdings |
1 |
| #153 |
Shannon Hogan |
Dyax |
1 |
| #153 |
Mikhail Filippov |
Irobot |
1 |
| #153 |
Kannan Tharakaraman |
MIT |
1 |
| #153 |
Christopher Papile |
Badger Licensing |
1 |
| #153 |
Thomas Gonsiorowski |
Sunrise R&D Holdings |
1 |
| #153 |
Michelle Madar |
Bristol-Myers Squibb |
1 |
| #153 |
Patrick J. Bell |
MIT |
1 |
| #153 |
Victor Rivera |
Ariad Gene Therapeutics |
1 |
| #153 |
Benjamin Stone Amidon |
Millennium Pharmaceuticals |
1 |
| #153 |
Upkar Singh |
— |
1 |
| #153 |
Manuel A. Baldera |
IBM |
1 |
| #153 |
David Eric Saff |
Google |
1 |
| #153 |
Marc Zacharias |
— |
1 |
| #153 |
Judith G. Siegel |
Fresenius Medical Care Holdings |
1 |